Comments by two Federal Reserve officials indicating that a rate hike was possible before the end of the year sent the markets down to a lower close with the Dow tumbling 84 points to 18,552. Nasdaq dropped 34 points to 5,227.
On the upside
Comstock Resources (NYSE: CRK) amended its previously announced senior notes exchange offer.
Cintas (Nasdaq: CTAS) will acquire G&K Services (Nasdaq: GK) in a deal valued at approximately $2.2 billion.
Shares of Cyclacel Pharmaceuticals (Nasdaq: CYCC) extended its gains.
On the downside
Evoke Pharma (Nasdaq: EVOK) narrowed losses for the second quarter but the stock price fell.
Heat Biologics (Nasdaq: HTBX) narrowed second quarter losses but the stock price slipped.
Investors locked in profits on Ocular Therapeutics (Nasdaq: OCUL).
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 3 on both the NYSE and on Nasdaq. The broader S&P 500 dropped 12 points to 2,178. Bitcoin climbed $13 to $578.
